C-Arms Market Size & Outlook, 2025-2033

C-Arms Market Overview

The global c-arms market size was valued at USD 2.33 billion in 2024 and is expected to grow from USD 2.45 billion in 2025 to reach USD 3.7 billion in 2033, growing at a CAGR of 5.25% during the forecast period (2025–2033). Increasing demand for sophisticated imaging technologies, coupled with the expanding geriatric population and prevalence of chronic illnesses, is driving market growth.

Key Market Indicators

• North America dominated the c-arms industry and accounted for a 53.89% share in 2024, fueled by strong healthcare infrastructure, chronic disease prevalence, high spending, and rising elective surgeries.
• Based on type, the Mobile C-arms held the largest share of approximately 36.59% of the market in 2024, driven by flexibility and innovations like Philips Zenition, while fixed C-arms grow via cardiology and chronic disease demand.
• Based on application, Cardiology leads the market with 5.5% CAGR, driven by rising CVD cases, while Orthopedics & Trauma follows, fueled by trauma prevalence and surgical demand.

Market Size & Forecast

• 2024 Market Size: USD 2.33 billion
• 2033 Projected Market Size: USD 3.7 billion
• CAGR (2025–2033): 5.25%
• Largest market in 2024 : North America
• Fastest-growing region : Europe

Imaging techniques are becoming a need that can be found in practically all hospitals with adequate equipment. For intraoperative imaging, surgeons, orthopedic surgeons, traumatologists, vascular surgeons, and cardiologists employ C-arms. A C-arm machine identifies itself as an advanced medical imaging device operating on X-ray technology's core premise. A C-Arm device is a sophisticated X-ray-based medical imaging instrument. They are mainly utilized for their fluoroscopy skills, though they also have radiography capabilities.

The C-Arm is so named because of its C-shaped arm, which transmits the x-ray source to the detector. The type of C-Arm selected depends on the procedures to be performed. C-Arm selection requires complete clarity regarding its intended use.

Numerous market participants make continuous efforts to develop advanced systems, such as the incorporation of Artificial Intelligence (AI)-enabled advancements and 3D mapping functionality in a C-arm system that will strengthen process planning, increase real-time intraoperative guidance, and significantly decrease surgical operation times.

The primary factors driving the market's expansion are the increasing elderly population, the prevalence of chronic diseases, advances in mobility and imaging abilities, and the demand for imaging technologies in emerging nations. In addition, C-arms are now utilized in various medical fields, and their uses are anticipated to expand. The market for C-arms is driven by these reasons and the rising demand for a healthcare system in developing nations.

To get more insights about this report Download Free Sample Report

C-Arms Market Growth Factor

The Growing Geriatric Population and the Prevalence of Chronic Illnesses

The increasing senior population and the burden of chronic diseases are two of the primary drivers driving the expansion of the C-arm market; as the percentage of elderly patients increases, so does the number of surgical procedures.

According to the International Agency for Research on Cancer (IARC), part of WHO, forecasts over 35 million new cancer cases by 2050, a 77% increase from the 20 million in 2024. According to the American Cancer Society, in 2024, there were approximately 2,001,140 new cancer cases and 611,720 cancer deaths across the United States alone. This propelled the market, as C-arm machines are used as intraoperative imaging devices for cancer, orthopedics, cardiology, neurology, etc., surgeries.

Additionally, according to the American Heart Association’s 2025 update, the global prevalence of cardiovascular disease (CVD) in 2021 was estimated at approximately 612.06 million people in 2025 as opposed to 271 million in 1990. CVD deaths have risen from 12.1 million in 1990 to 18.6 million in 2019. As C-arms are utilized for intraoperative imaging during surgical procedures, the increase in cardiovascular disorders will stimulate the market. As chronic diseases are more prevalent among the elderly, aging is a contributing cause to their increasing prevalence.

In coming years, there are expected to be 727 million people worldwide who are 65 or older, estimates by the Population Division of the UN Department of Economic and Social Affairs. The number of senior citizens worldwide is predicted to double in the coming three decades, surpassing over 1.5 billion in 2050. Chronic diseases are becoming more common as the population ages, aiding the market's expansion. As a result, the market for C-arms is anticipated to expand throughout the forecast period, especially in light of factors like the growing elderly population and the burden of chronic diseases.

Market Restraint

Cost of Procedure and Equipment

The healthcare infrastructure in developed countries like the United States, Canada, and Germany is robust. In contrast, developing countries struggle to have a better healthcare infrastructure as medical treatment costs rise yearly. Additionally, modern technology is required for better healthcare facilities, which is again a market constraint due to the high cost of the equipment.

• For instance, according to Medical Economics, global medical costs are projected to increase by 10.4% in 2025, continuing double-digit growth for the third consecutive year.

• The World Health Organization (WHO) reports that in 2025, at least 70 countries are seeing patients denied access to essential medical care due to aid cuts. This has led to facility closures, job losses, and increased out-of-pocket burdens on patients. 

These two elements will prevent the market from expanding. Cancer, one of the most lethal diseases, , requires prompt treatment, but the market is constrained by the high cost of surgeries and equipment.

Furthermore, adaptable C-arms are typically expensive, as implied by their advanced components and features. This demonstrates why small businesses and new entrants can't make the necessary effort to purchase these C-arm imaging devices. Thus, restricting the C-arms market from expanding.

Market Opportunity

Increased Advancements in the Field

Over the forecast period, the increase in public-private funding for targeted research activities, the popularization of personalized medicine, and the rise in product innovations and development due to global technological advancements will create lucrative opportunities for market participants.

• For instance, in 2025 the European Commission approved $471 million in public funding to support innovation in medical devices, particularly incorporating digital and AI features. This investment is expected to stimulate an additional $966 million in private investments and create approximately 800 jobs.

Additionally, the growing number of strategic alliances, the rising rate of internet penetration, the growing number of hospitals and laboratories, the increasing demand for minimally invasive surgical operations in developing regions, and the rising per capita healthcare spending will all contribute to the market's future growth. Developing new implementations for C-Arms devices will also bolster its market growth in the future.

• For instance, in 2025, Siemens Healthineers introduced the CIARTIC Move, a fully motorized self-driving C-arm equipped with holonomic, omnidirectional wheels. The system can be controlled remotely, allowing it to maneuver with high precision even in constrained operating room spaces. This innovation enables up to 50% faster intraoperative imaging, reducing both technician workload and idle time during surgeries.

• In May 2025, researchers developed Virtual Fluoroscopy, a technique that merges magnetic instrument tracking with C-arm imaging. This approach creates virtual fluoroscopic views with enhanced depth perception during procedures. It achieved high accuracy with targeting errors of less than 2 mm, improving surgical precision.

C-Arms are used in intraoperative 3D, minimally invasive surgery, hybrid operating rooms, interventional angiography, radiology, cardiology, surgical navigation, orthopedics, neurology, gallbladder, liver, and bone imaging, diagnostic testing, kidney drainage, percutaneous valve replacements, abdominal and thoracic aortic aneurysm repair, cardiac surgery, vascular surgery, gastroenterology, and neurostimulation. New devices such as FL C-Arm, Philips c-arm, GE c-arm, and Siemens c-arm are utilized for this aim. Thus, product development will result in more market opportunities.

Regional Insights

In 2024, North America held the largest share of 53.89% in the C-arms market and is expected to expand at a CAGR of 4.85% over the forecast period. A fair reimbursement system, rising adoption of cutting-edge technologies, an upgraded healthcare infrastructure, and consumers with significant purchasing power all contribute to the market's growth. The Centers for Medicare and Medicaid Services reported that the United States spending in 2024 climbed about 8.2%, surpassing $5.3 trillion, and healthcare’s share of GDP grew to roughly 18.0%.

Additionally, it is anticipated that the region's demand for C-arm equipment will expand because of elective surgery rates following the pandemic and the rising frequency of chronic diseases.

The region's high standards for healthcare infrastructure, the aging society, an increase in the frequency of chronic illnesses, and frequent medical testing are additional factors projected to promote market expansion. According to the Centers for Disease Control and Prevention approximately 60% of U.S. adults had at least one chronic condition in 2024, while 40% suffered from multiple chronic conditions (MCC). In 2025 chronic and mental health conditions accounted for 90% of the nation's $4.9 trillion in annual healthcare expenditures.

According to the 2025 AHA Heart Disease and Stroke Statistics Update, there were 941,652 cardiovascular deaths in the U.S. As a result, more surgeries are performed due to chronic illnesses, which raises the demand for imaging equipment like C-arms.

Europe Market Trends

Europe will expand at a CAGR of 4.78%, accounting for USD 812 million by 2030. The European medical system provides access to cutting-edge advanced technologies for patients and is a lucrative market for most diagnostic companies. The demand for C-arms is influenced by the rise in chronic illnesses, aging populations, and technological advancements.

• According to the 15th Coordinated Population Projection, approximately 16.9 million people aged 67 or older are expected representing roughly 20% of Germany’s total population By 2040, this proportion is projected to increase to 21.4 million.
• In 2025 Ziehm Imaging, based in Nuremberg, launched a groundbreaking mobile C-arm that integrates endovascular navigation with AI-powered image fusion; merging preoperative CT scans and live fluoroscopy into a single interface. The system provides higher precision, automated re-registration after repositioning, and reduced radiation and contrast use.

The need for C-arms devices is fueled by the growing geriatric population, which makes these populations more susceptible to orthopedic, cardiovascular, and neurological conditions that call for surgery.

Type Insights

The market is categorized into Fixed C-arms and Mobile C-arms. The mobile C-arms segment accounted for the largest market share of 36.59% in 2024 and is projected to grow at a CAGR of 5.51% over the forecast period. Based on X-ray technology, a mobile C-arm is a flexible medical imaging tool that can be utilized in different operating rooms (ORs) throughout a clinic. The device's name comes from the C-shaped arm that joins the X-ray source and detector. The segment is anticipated to have considerable growth over the forecast period due to technical developments in the region and the introduction of new mobile C-arm platforms.

• For instance, Royal Philips introduced the Philips Zenition mobile C-arm platform to improve operating room performance and workflow efficiency in February 2019.

The Fixed C-arms section will hold the second-largest market share. The fixed C-arm is a stationary imaging technology typically installed in a designated space, known as Cath Labs. Compared to mobile C-arms, they usually occupy a more prominent position in the space. Aside from angiography, therapeutics, and orthopedic treatments, cardiology procedures are the primary uses of fixed C-arms.

The market for fixed C-arm devices is anticipated to rise along with the incidence of chronic diseases in the world, fueling the expansion of this market. Companies are constantly inventing new technologies and refining their already existing ones. They are also involved in other business expansion initiatives, including mergers, acquisitions, and strategic alliances, which are expected to support the expansion of the fixed C-arm market sector.

Application Insights

The market is categorized into Cardiology, Gastroenterology, Neurology, Orthopedics & Trauma, Oncology, and Other Applications. The Cardiology section is projected to advance at a CAGR of 5.5% and hold the largest market share over the forecast period. C-arm imaging devices are crucial to effectively managing several cardiovascular disorders, including atherosclerosis, ischemic-reperfusion injury, and other microvascular diseases, including hypertension.

The main factor fueling the segment's rise is an upsurge in cardiovascular disease (CVD) occurrences worldwide. For instance, according to the WHO 2021 report, cardiovascular illnesses remain the most significant cause of mortality worldwide. In 2019, 17.9 million people died from cardiovascular diseases or nearly 32 % of all deaths. Cardiology treatments for cardiac imaging utilize imaging systems built on C-arm platforms. They can create 3D images of the cardiac anatomy, which is particularly helpful during cardiac surgeries.

The Orthopedics & Trauma section is projected to have the second-largest market share. Due to the rising prevalence of orthopedic illnesses, the increasing number of severe trauma cases, and technological developments in the goods, the orthopedics and trauma segment of the C-arms market is anticipated to increase throughout the projected period. Nowadays, trauma and orthopedic operations require C-arm fluoroscopy as a vital tool. A crucial reason driving the segment's growth is that it enhances the surgeon's technical proficiency and, as a result, lowers the patients' morbidity and duration of hospital stay.

List of key players in C-Arms Market

1. Canon Medical Systems Corporation
2. GE Healthcare
3. Hologic Corporation
4. Koninklijke Philips NV
5. FUJIFILM Holdings Corporation
6. Shimadzu Corporation
7. Siemens Healthcare
8. Ziehm Imaging GmbH
9. AADCO Medical, Inc.
10. Allengers Medical Systems Ltd

To get more findings about this report Download Market Share

Recent Developments

• In May 2025 : Medicatech USA received FDA 510(k) clearance for its mini C-arm imaging system, marking a notable entry into the market with a focus on compact and mobile imaging solutions.